LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
6.55
-0.20 (-2.96%)
Jan 12, 2026, 4:00 PM EST - Market closed

LeonaBio Statistics

Total Valuation

LeonaBio has a market cap or net worth of $25.83 million. The enterprise value is $1.52 million.

Market Cap25.83M
Enterprise Value 1.52M

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date Feb 20, 2026
Ex-Dividend Date n/a

Share Statistics

LeonaBio has 3.94 million shares outstanding. The number of shares has increased by 1.93% in one year.

Current Share Class 3.94M
Shares Outstanding 3.94M
Shares Change (YoY) +1.93%
Shares Change (QoQ) +0.88%
Owned by Insiders (%) 12.86%
Owned by Institutions (%) 26.56%
Float 981,205

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.96
P/TBV Ratio 0.96
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.70, with a Debt / Equity ratio of 0.03.

Current Ratio 9.70
Quick Ratio 9.05
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -89.42% and return on invested capital (ROIC) is -56.68%.

Return on Equity (ROE) -89.42%
Return on Assets (ROA) -42.21%
Return on Invested Capital (ROIC) -56.68%
Return on Capital Employed (ROCE) -144.12%
Revenue Per Employee n/a
Profits Per Employee -$1.11M
Employee Count26
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +19.45% in the last 52 weeks. The beta is 2.80, so LeonaBio's price volatility has been higher than the market average.

Beta (5Y) 2.80
52-Week Price Change +19.45%
50-Day Moving Average 5.16
200-Day Moving Average 3.88
Relative Strength Index (RSI) 54.73
Average Volume (20 Days) 3,214,422

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -39.27M
Pretax Income -37.72M
Net Income -37.72M
EBITDA -38.30M
EBIT -39.27M
Earnings Per Share (EPS) -$9.66
Full Income Statement

Balance Sheet

The company has $25.23 million in cash and $912,000 in debt, with a net cash position of $24.31 million or $6.16 per share.

Cash & Cash Equivalents 25.23M
Total Debt 912,000
Net Cash 24.31M
Net Cash Per Share $6.16
Equity (Book Value) 26.79M
Book Value Per Share 6.79
Working Capital 24.24M
Full Balance Sheet

Cash Flow

Operating Cash Flow -52.35M
Capital Expenditures n/a
Free Cash Flow -52.35M
FCF Per Share -$13.27
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LeonaBio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.93%
Shareholder Yield -1.93%
Earnings Yield -146.03%
FCF Yield -202.63%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 18, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date Sep 18, 2025
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 1